Stockscreener 앱 받기
1.24
6.77%
-0.09
시간 외 거래:
1.24
전일 마감가:
$1.33
열려 있는:
$1.32
하루 거래량:
4.21M
Relative Volume:
9.29
시가총액:
$66.33M
수익:
$96.63M
순이익/손실:
$-63.32M
주가수익비율:
-0.8493
EPS:
-1.46
순현금흐름:
$-54.55M
1주 성능:
-1.59%
1개월 성능:
-2.36%
6개월 성능:
-48.12%
1년 성능:
-49.18%
1일 변동 폭
$1.24
$1.3678
1주일 범위
$1.195
$1.3678
52주 변동 폭
$0.931
$3.42
아코야 바이오 Stock (AKYA) Company Profile
명칭
Akoya Biosciences Inc
전화
855.896.8401
주소
100 CAMPUS DRIVE, MARLBOROUGH
AKYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKYA
Akoya Biosciences Inc
|
1.24 | 66.33M | 96.63M | -63.32M | -54.55M | -1.46 |
|
ISRG
Intuitive Surgical Inc
|
533.71 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
170.86 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.81 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.16 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.87 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
아코야 바이오 Stock (AKYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2024-08-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-08-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-21 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-02-02 | 개시 | UBS | Buy |
| 2022-11-03 | 개시 | CapitalOne | Overweight |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-06-22 | 개시 | BTIG Research | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-05-11 | 개시 | Canaccord Genuity | Buy |
| 2021-05-11 | 개시 | JP Morgan | Overweight |
| 2021-05-11 | 개시 | Morgan Stanley | Overweight |
| 2021-05-11 | 개시 | Piper Sandler | Overweight |
모두보기
아코야 바이오 주식(AKYA)의 최신 뉴스
Transcript : Akoya Biosciences, Inc.Special Call - MarketScreener
Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by Jane Street Group LLC - Defense World
Deutsche Bank AG Raises Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences (AKYA) Receives Price Target Cut from Morgan S - GuruFocus
Akoya Biosciences (AKYA) Receives Price Target Cut from Morgan Stanley | AKYA Stock News - GuruFocus
Northern Trust Corp Buys 39,799 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Spatial proteomics Market Worth Observing Growth: Bruker, Akoya Biosciences, PerkinElmer - newstrail.com
Spatiotemporal Omics Market Research Report 2025-2035, Competitive Analysis of Prominent Players10X Genomics, Akoya Biosciences, Bruker, Curio Bioscience, IonPath, MGI, and RareCyteResearchAndMarkets.com - FinancialContent
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of “Hold” from Brokerages - Defense World
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga
Quanterix Merger Drama: 6.9% Holder Fights Board as Rival $1.40 Cash Offer Threatens Deal - Stock Titan
Akoya surges as unsolicited buyout offer risks Quanterix merger - MSN
Akoya Biosciences (AKYA) Soars on New Acquisition Proposal - GuruFocus
An undisclosed buyer agreed to acquire Akoya Biosciences, Inc.. - marketscreener.com
Akoya Biosciences Receives Unsolicited Buyout Offer From Third Party - marketscreener.com
Akoya Biosciences considering unsolicited buyout amidst merger proceedings - Worcester Business Journal
Akoya stock surges as new buyout bid risks Quanterix deal (AKYA) - Seeking Alpha
Akoya Biosciences reviews unsolicited acquisition proposal By Investing.com - Investing.com Nigeria
Akoya Biosciences reviews unsolicited acquisition proposal - Investing.com India
Akoya Biosciences IncOn May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing - marketscreener.com
Akoya Biosciences (NASDAQ:AKYA) Given New $1.08 Price Target at Canaccord Genuity Group - Defense World
Akoya Biosciences Reports Q1 2025 Financial Results - TipRanks
Akoya Biosciences (AKYA) Target Price Reduced by Canaccord | AKY - GuruFocus
Akoya Biosciences (AKYA): Analyst Lowers Price Target | AKYA Sto - GuruFocus
Akoya Biosciences (AKYA): Analyst Lowers Price Target | AKYA Stock News - GuruFocus
Akoya Biosciences (AKYA) Target Price Reduced by Canaccord | AKYA Stock News - GuruFocus
Akoya Biosciences (AKYA) Faces Uncertainty Amid Merger and Marke - GuruFocus
Akoya Biosciences, Inc. SEC 10-Q Report - TradingView
Akoya: Q1 Earnings Snapshot - The Washington Post
Akoya Biosciences earnings missed by $0.11, revenue fell short of estimates - Investing.com Canada
Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Akoya Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Akoya Biosciences Inc Reports Q1 2025 Earnings: EPS of -$0.18 Be - GuruFocus
Akoya Biosciences Reports First Quarter 2025 Financial Results - The Manila Times
Akoya Biosciences (AKYA) Projected to Post Quarterly Earnings on Monday - Defense World
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire
Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Acquired by JPMorgan Chase & Co. - Defense World
Quanterix and Akoya Biosciences Announce Amended Merger Agreement - ADVFN
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Recommendation of “Hold” by Analysts - Defense World
Canaccord Genuity Group Has Lowered Expectations for Akoya Biosciences (NASDAQ:AKYA) Stock Price - Defense World
AKYA Merger Faces Backlash Amid Shareholder Discontent | AKYA St - GuruFocus
Quanterix Acquisition of Akoya Biosciences (AKYA) Faces Challenges | AKYA Stock News - GuruFocus
Kent Lake Issues Statement on Quanterix?s Amendment to Merger with Akoya Biosciences - marketscreener.com
Quanterix, Akoya Biosciences Amend Merger Deal - marketscreener.com
Akoya stock falls on amended Quanterix merger deal (AKYA) - Seeking Alpha
Quanterix Revises Merger Terms with Akoya Biosciences - TipRanks
Merger Amendment: Changes to Quanterix and Akoya Biosciences (AK - GuruFocus
Quanterix And Akoya Biosciences Announce Amended Merger Agreement - marketscreener.com
Canaccord Adjusts Price Target for Akoya Biosciences (AKYA) | AK - GuruFocus
Akoya Biosciences introduces new assay for breast cancer ADC development By Investing.com - Investing.com South Africa
아코야 바이오 (AKYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
0.15%
자본화:
|
볼륨(24시간):